Management of Relapsed–Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical Practice

SIMPLE SUMMARY: Multiple myeloma is an incurable hematologic malignancy arising from terminally differentiated B-cells. Over the last decade, advancements in therapeutics have radically shifted the treatment landscape of MM, significantly improving the survival of patients. In this review, we will d...

Descripción completa

Detalles Bibliográficos
Autores principales: Dima, Danai, Ullah, Fauzia, Mazzoni, Sandra, Williams, Louis, Faiman, Beth, Kurkowski, Austin, Chaulagain, Chakra, Raza, Shahzad, Samaras, Christy, Valent, Jason, Khouri, Jack, Anwer, Faiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093129/
https://www.ncbi.nlm.nih.gov/pubmed/37046821
http://dx.doi.org/10.3390/cancers15072160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093129/
https://www.ncbi.nlm.nih.gov/pubmed/37046821
http://dx.doi.org/10.3390/cancers15072160

Ejemplares similares